Vanda Pharmaceuticals Inc (NASDAQ:VNDA)
| 5.95 Delayed Data As of 4:00pm ET |  -0.015 / -0.25%Today’s Change | 5.75 Today|||52-Week Range 11.90 | -19.55% Year-to-Date |
Latest VNDA News | Press Releases
No recent news for Vanda Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.96 |
| Today’s open | 6.09 |
| Day’s range | 5.93 - 6.09 |
| Volume | 25,893 |
| Average volume (3 months) | 561,139 |
| Market cap | $351.6M |
Data as of 4:00pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | -81.38% |
| Earnings growth (this year) | -500.00% |
| Earnings growth (next 5 years) | +36.12% |
| Revenue growth (last year) | -5.32% |
| P/E ratio | 21.2 |
| Price/Sales | 1.66 |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XERSXeris Biopharma Hold... | -0.00 | -0.19% |
| ---- | ||
| ASRTAssertio Holdings In... | -0.13 | -2.01% |
| YMABY-mAbs Therapeutics ... | -0.16 | -1.93% |
Data as of 4:00pm ET, 05/31/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $254.4M |
| Annual profit (last year) | $6.3M |
| Net profit margin | 2.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
